YS Biopharma Co., Ltd. Ordinary Shares (YS) Stock

DelistedNasdaq: YSYS Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer.

0.48
Final close · Jul 26, 2024

YS is no longer traded. YS Biopharma Co., Ltd. Ordinary Shares was delisted from the Nasdaq in July 2024.

Prices on this page are historical; the last trade was July 26, 2024 at $0.48.

YS Biopharma Co., Ltd. Ordinary Shares stock price history

Split-adjusted closes, 2023–2024

YS final trading statistics

Final close
$0.48
Final trading day
Jul 26, 2024
Market cap at delisting
$192.09M
Shares outstanding
188.33M
Final 52-week range
$0.35 – $1.45
Avg. volume (final 3 mo.)
55,824
All-time high (split-adj.)
$13.00 · Mar 2023
All-time low (split-adj.)
$0.37 · Feb 2024
Return since IPO
-95.0%
Beta
0.54
Book value / share
$5.10
Price / book
0.09
Final 52 wk
0.351.45

YS Biopharma Co., Ltd. Ordinary Shares earnings per share

Earnings per share

YS Biopharma Co., Ltd. Ordinary Shares revenue & net income

RevenueNet income

YS Biopharma Co., Ltd. Ordinary Shares annual financials

YS Biopharma Co., Ltd. Ordinary Shares revenue, net income and EPS by fiscal year
Fiscal yearRevenueNet incomeEPS
FY2023$687.20M-$145.5M—
FY2022$502.95M-$106.0M-$0.16
FY2021$257.02M-$191.8M—

Last five fiscal years reported before the delisting; fiscal year ending March. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.

About YS Biopharma Co., Ltd. Ordinary Shares

YS Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was founded in 2002 and is based in Beijing, China.

YS Biopharma Co., Ltd. Ordinary Shares stock FAQ

What happened to YS Biopharma Co., Ltd. Ordinary Shares stock?

YS Biopharma Co., Ltd. Ordinary Shares stock was delisted from the Nasdaq. Its final close was $0.48 on July 26, 2024.

Is YS stock still trading?

No. YS was delisted from the Nasdaq in July 2024 and no longer trades on a U.S. exchange.

What was the last price of YS stock?

YS closed at $0.48 on its final trading day, July 26, 2024, for a market value of about $192.09M.

What were YS Biopharma Co., Ltd. Ordinary Shares's revenue and earnings in its last full fiscal year?

YS Biopharma Co., Ltd. Ordinary Shares reported revenue of $687.20M and net income of -$145.5M in fiscal 2023, its last full year as a public company.

When did YS Biopharma Co., Ltd. Ordinary Shares go public?

YS Biopharma Co., Ltd. Ordinary Shares stock began trading on March 16, 2023.

Biotechnology stocks to research

All Healthcare stocks →